Abel Hall LLC
INSM icon

Abel Hall LLC’s Insmed INSM Stock Holding History

Abel Hall LLC’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$290K Sell
2,539
-27
-1% -$3.18K 0.05% 456
2026
Q2 		$274K Sell
2,566
-524
-17% -$63.4K 0.05% 533
2026
Q1 		$505K Buy
3,090
+471
+18% +$72.4K 0.11% 190
2025
Q4 		$456K Buy
2,619
+61
+2% +$11.1K 0.11% 196
2025
Q3 		$368K Sell
2,558
-903
-26% -$111K 0.15% 132
2025
Q2 		$348K Sell
3,461
-810
-19% -$61.9K 0.16% 135
2025
Q1 		$326K Buy
4,271
+938
+28% +$71.8K 0.2% 88
2024
Q4 		$230K Buy
3,333
+151
+5% +$10.9K 0.15% 116
2024
Q3 		$232K Buy
+3,182
New +$235K 0.15% 117

Other funds holding INSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Abel Hall LLC's INSM Position: Q3 2026 in Review

Abel Hall LLC reduced its Insmed (INSM) stake by 1.1% in Q3 2026, selling an estimated $3.18K and leaving 2,539 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #456.

Abel Hall LLC first reported a position in INSM in Q3 2024 and has held it in 9 quarters since. The position peaked at $505K in Q1 2026. 214 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Abel Hall LLC held 2,539 shares of Insmed worth $290K as of Q3 2026.
  • Abel Hall LLC sold 27 Insmed shares in Q3 2026, an estimated $3.18K.
  • Insmed made up 0.05% of Abel Hall LLC's portfolio in Q3 2026, its #456 holding.
  • Abel Hall LLC first reported a position in Insmed in Q3 2024 and has held it in 9 quarters since.
  • Abel Hall LLC's Insmed position peaked at $505K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.